AHA News: Dangerous Bleeding Strokes Disproportionately Affect Asian American, Pacific Islander Adults

Asian and Pacific Islander adults in the U.S. are disproportionately affected by a deadly type of stroke that causes bleeding into the brain, according to new research that also shows they experience these strokes at a younger age than their white peers.

With these intracerebral hemorrhages, or ICHs, they also face greater complications and longer hospital stays than their white counterparts, according to the findings recently published in JAMA Network Open. They are being presented Wednesday at the American Stroke Association's International Stroke Conference.

ICH strokes occur when blood vessels in the brain rupture and bleed. They account for 10%-15% of the estimated 795,000 strokes each year in the U.S., according to American Heart Association statistics. They are more deadly and more likely to cause long-term disability than other types of stroke.

While it's well known that ICH is more common in Asian adults in other countries, this was the first large study to quantify the disparity among people of Asian descent living in the U.S., said study senior author Farhaan Vahidy, associate director of the Center for Outcomes Research at Houston Methodist.

"The risk of ICH among people who live in Asian countries is much higher than for those who live in Europe or South America," said Vahidy, who also is an associate professor of research in the department of population health sciences at Weill Cornell Medical College in New York City. "But what we did not know before our study was, does that risk translate to Asian populations living in the U.S.?"

Researchers analyzed nationwide hospital data for 803,230 Black, white, Hispanic and Asian American and Pacific Islander adults who experienced ICH strokes from 2004 to 2018. The average age was 69, with a nearly even split of men and women.

Asian and Pacific Islander adults experienced ICH strokes at a rate of 22.18 for every 100,000 people. This was similar to the rate for white adults, which was 22.86 for every 100,000 people. Black adults had the highest rate, at 34.33, while Hispanic adults had the lowest, at 15.77.

However, when comparing the proportion of ICH strokes to other types of stroke, Asian American and Pacific Islander adults experienced them at higher percentages than any other racial and ethnic group – 18.9%. That's compared to 14.1% for Hispanic adults, 12.2% for Black adults and 11.1% for white adults. In addition, for every one-year increase in age at the time of their stroke, Asian and Pacific Islander patients were 1% more likely to die compared to their white counterparts.

The analysis found Asian American and Pacific Islander adults also had strokes at a younger age than their white peers – 66.3 versus 72. They also were more likely to experience severe illness, greater disability, be put on a ventilator and require other more extensive treatments that resulted in longer, more expensive hospital stays.

Seeing greater disease severity at a younger age was surprising, Vahidy said, given that ICH typically affects older stroke patients more severely than younger ones.

Vahidy leads a team of researchers presenting findings at the stroke conference from a related study that found an 11% overall increase in the rate of ICH during the same study period, with rates increasing faster for adults under age 65 compared to those 75 and older.

This study looked closer at how ICH was affecting racial and ethnic groups, revealing the disparity for Asian American and Pacific Islander adults. The next question to answer, Vahidy said, is why this is happening. Is it genetics, lifestyle or a combination of both?

The findings suggest a role for stroke risk factors. Compared to white people, researchers found Asian American and Pacific Islander adults were more likely to have high blood pressure, high cholesterol, diabetes and to have experienced an ischemic stroke, the most common type which is caused by a clot. They also were less likely to be prescribed anticoagulant drugs to help prevent blood clots that can lead to a heart attack or stroke.